Check for other causes
The treatment increased skin density and thickness, reduced fine lines and the depth of wrinkles, reduced photodamage and hyperpigmentation, improved skin clarity, and increased keratinocyte proliferation
So if this is not a pat, a patentable, like if it's not something you could put on patent, probably there are not gonna be a lot of, uh, pharma guys who are gonna really want to invest in it because you can't protect it
353b), the FAQs state that compounding drugs, including GLP-1s, is appropriate either when the drug is not commercially available (including if there is an FDA-declared shortage) or when the compounded drug includes a change, made for an identified individual patient, which produces for that patient a significant difference, as determined by the prescribing practitioner, between the compounded drug and the commercially available product. In short, compounding pharmacies will no longer be able to produce copies of commercially available drugs, including GLP-1s
InzucchiSEBergenstalRMBuseJBDiamantMFerranniniENauckMet al
GLP-1 (peptide-1 simile al glucagone)